Stockscreener 앱 받기
1.35
3.57%
-0.05
시간 외 거래:
1.12
-0.23
-17.04%
전일 마감가:
$1.40
열려 있는:
$1.4
하루 거래량:
171.21K
Relative Volume:
0.15
시가총액:
$15.28M
수익:
-
순이익/손실:
$-9.70M
주가수익비율:
-1.2273
EPS:
-1.1
순현금흐름:
$-8.57M
1주 성능:
-13.46%
1개월 성능:
-10.60%
6개월 성능:
-26.63%
1년 성능:
-72.11%
1일 변동 폭
$1.2901
$1.4048
1주일 범위
$1.2901
$1.61
52주 변동 폭
$0.95
$5.95
마커 테라퓨틱스 Stock (MRKR) Company Profile
명칭
Marker Therapeutics Inc
전화
(713) 400-6400
주소
2450 HOLCOMBE BLVD, HOUSTON, TX
MRKR을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
MRKR
Marker Therapeutics Inc
|
1.35 | 15.84M | 0 | -9.70M | -8.57M | -1.10 |
|
VRTX
Vertex Pharmaceuticals Inc
|
462.13 | 117.32B | 11.10B | -988.90M | -1.26B | -3.92 |
|
REGN
Regeneron Pharmaceuticals Inc
|
558.87 | 58.89B | 14.09B | 4.50B | 2.96B | 39.28 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
401.80 | 51.14B | 2.46B | -319.09M | -52.09M | -2.47 |
|
ARGX
Argen X Se Adr
|
673.80 | 41.02B | 2.58B | 1.06B | -1.28B | 16.33 |
|
ONC
Beone Medicines Ltd Adr
|
299.01 | 32.59B | 3.81B | -644.79M | -669.77M | -6.24 |
마커 테라퓨틱스 Stock (MRKR) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-03-05 | 개시 | Canaccord Genuity | Buy |
| 2021-03-25 | 개시 | Piper Sandler | Overweight |
| 2021-03-19 | 개시 | Cantor Fitzgerald | Overweight |
| 2020-05-12 | 다운그레이드 | Piper Sandler | Overweight → Neutral |
| 2019-05-30 | 개시 | ROTH Capital | Buy |
| 2019-03-01 | 개시 | Janney | Buy |
| 2018-12-03 | 업그레이드 | Piper Jaffray | Neutral → Overweight |
모두보기
마커 테라퓨틱스 주식(MRKR)의 최신 뉴스
Using Ichimoku Cloud for Marker Therapeutics Inc. technicalsInvestment Timing Strategy with Market Filters - Newser
Why Marker Therapeutics Inc. stock attracts strong analyst attentionWeekly Price Target Forecast and Alerts - Newser
How many analysts rate Marker Therapeutics Inc. as a “Buy”Free Stock Trend Scanner For 2025 - jammulinksnews.com
Is Marker Therapeutics Inc. stock overvalued or undervaluedExpert Picks Outlook To Watch Now - jammulinksnews.com
What MACD signals say about Marker Therapeutics Inc.Volatility Analysis and Entry Risk Mapping - Newser
Applying big data sentiment scoring on Freshworks Inc.Free Market Surge Signal for Swing Traders - Newser
Comparing Marker Therapeutics Inc. in custom built stock radarsInsider Strategy for High Conviction Picks - Newser
How strong is Marker Therapeutics Inc. company’s balance sheetBreakout Stocks Strategy With Low Risk - jammulinksnews.com
Will Marker Therapeutics Inc. see short term momentumNeural Model for Stock Price Movement - Newser
What makes Marker Therapeutics Inc. stock price move sharplyWealth Building Data Feed For Every Investor - jammulinksnews.com
What catalysts could drive Marker Therapeutics Inc. stock higher in 2025Wealth Building Target Finder For Every Investor - jammulinksnews.com
Ranking Marker Therapeutics Inc. among high performing stocks via toolsFree Early Entry Tips With Low Risk Zone - Newser
How Efficient Is Marker Therapeutics Inc. at Controlling Operating CostsHigh Conviction Stock Long-Term Summary - Newser
What makes Marker Therapeutics Inc. stock attractive to long term investorsFree Earnings Play Trade Plan With Alerts - Newser
How hedge fund analytics apply to OXLCP stockReal Trader Watchlist with Entry Targets - Newser
Multi asset correlation models including Marker Therapeutics Inc.AI Trade Signal Forecast with Chart Logic - Newser
Is Marker Therapeutics Inc. a Top Dividend Stock to Watch in 2025Free Risk Adjusted Technical Entry Plan - Newser
Applying chart zones and confluence areas to Marker Therapeutics Inc.Free Fast Gaining Stock Screener Report - Newser
Is Marker Therapeutics Inc. Stock a Smart Buy in 2025 Investment Analysis Inside - Newser
Price action breakdown for JACS.UFree Low Risk Swing Trade Opportunity List - Newser
Marker Therapeutics to Participate in a Fireside Chat at the Canaccord Genuity 45th Annual Growth Conference - GlobeNewswire
Marker Therapeutics (NASDAQ:MRKR) Trading Down 9% – Time to Sell? - Defense World
Marker Therapeutics, Inc. CEO Dr. Juan Vera to Speak at Canaccord Genuity 45th Annual Growth Conference - Quiver Quantitative
Marker Therapeutics CEO Reveals Latest T Cell Platform Progress: Exclusive Investor Access at Canaccord Conference - Stock Titan
What makes Diodes Incorporated stock price move sharplyInstitutional Holding Behavior Pattern Analysis - Newser
What data driven models say about HBAN’s futureDay Trading Setup and Momentum Analysis - Newser
Can SLRX rally from current levelsChart Driven Entry Timing for Swing Trades - Newser
How Unity Bancorp Inc. stock reacts to Fed policy changesCapital Protection Strategy With Risk Analysis - Newser
How to use Fibonacci retracement on GAM.PRBTrading Volume Spike and Reversal Analysis - Newser
Institutional scanner results for Zeo Energy Corp. Equity WarrantBuy Strategy Tracker with Growth Indicators - Newser
Why ASTH stock attracts strong analyst attentionSmart Trend Analysis With Buy Point Cues - Newser
Buy Signal for Q2 Holdings Inc. Stock Key Technical Indicators to WatchSafe Momentum Strategy With Trend Analysis - Newser
Why BRAG stock attracts strong analyst attentionSecure Buy Strategy Based on Risk Parameters - Newser
How to manage a losing position in Jin Medical International Ltd.Smart Entry Signals for Active Traders - Newser
How Marker Therapeutics Inc. stock performs during market volatilityInvestment Life Cycle Planning Summary - Newser
Marker Therapeutics shares fall 2.58% after-hours following positive ATH434 clinical trial results. - AInvest
What are the technical indicators suggesting about Marker Therapeutics Inc.Pre Market Target Finder For 2025 - jammulinksnews.com
New Product Launches: Will They Boost Fennec Pharmaceuticals Inc. Stock in 2025Weekly Market Direction and Sector Summary - Newser
Building trade automation scripts for Marker Therapeutics Inc.Daily Technical Chart Pattern Analysis Report - Newser
What makes CleanCore Solutions Inc. stock price move sharplyFree Beginner Friendly Stock Selection Guide - Newser
Is it the right time to buy Marker Therapeutics Inc. stockDiscover hidden gems in the stock market - jammulinksnews.com
How volatile is Marker Therapeutics Inc. stock compared to the marketFree Predictions - jammulinksnews.com
How does Marker Therapeutics Inc. compare to its industry peersMaximize returns with expert trading insights - jammulinksnews.com
Should I hold or sell Marker Therapeutics Inc. stock in 2025Build capital through low-risk investments - jammulinksnews.com
What are Marker Therapeutics Inc. company’s key revenue driversConsistently profitable trades - jammulinksnews.com
마커 테라퓨틱스 (MRKR) 재무 분석
매출
순이익
현금흐름
주당 순 이익
0.93%
0.15%
자본화:
|
볼륨(24시간):